In a phase 1 study of 10 adults with advanced retinitis pigmentosa, researchers found that optogenetic gene therapy combined ...
Chico Enterprise-Record on MSN
Enloe Health to receive $9M to expand cell, gene therapy access
Enloe Health announced Monday that was selected to receive a $9 million grant from the California Institute for Regenerative ...
This One Breakthrough Could Obliterate Disease — But What’s the Catch for Patients?”, “content”: “ Imagine a medical treatment that doesn’t just manage symptoms, but actually corrects the very ...
A Bengaluru infant diagnosed with Spinal Muscular Atrophy at just five weeks old has successfully received gene replacement ...
The FDA has approved 'Otarmeni', the first gene therapy for congenital hearing loss (DFNB9) caused by OTOF gene mutations.It ...
Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- "Preclinical Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
Editas Medicine (EDIT) downgraded to Hold as it pivots to in vivo CRISPR EDIT-401; timeline and cash runway into 2H 2028.
Spread the love“`html It’s a question humanity has pondered for millennia: can we truly slow, or even reverse, the aging ...
Late-breaking oral presentation at Retina Subspecialty Day outlines data from Beacon’s pivotal VISTA trial, which met its FDA ...
Known for its freezing winters, Finland is warming up to global entrepreuners and investors to boost its life science ...
REGENXBIO Inc. (Nasdaq: RGNX) today announced it will host an investor event at 1:00 p.m. ET on Tuesday, October 20, 2026 to review the surabgene lomparvovec (sura-vec, ABBV-RGX-314) clinical program ...
Dr. Shy's decades of work have helped identify CMT genes and establish research networks, while he has cared for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results